InvestorsHub on MSN

Allogene publishes promising ALLO-329 data in Nature Communications

Allogene Therapeutics (NASDAQ:ALLO) said new pre-clinical data for its investigational CAR-T therapy ALLO-329 have been ...

Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)

BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and ethionamide), an innovative drug combination that overcomes ...
The Manila Times

TME Pharma Announces Publication of NOX-A12 "Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications

TME Pharma Announces Publication of NOX-A12 'Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications ...